LBCA’s cross-country Lobular Breast Cancer Awareness Tour concludes on October 15th in Massachusetts. Launched after the ILC Symposium in San Francisco on September 26th,
October 15th Global Lobular Breast Cancer Awareness Day Events Around the World Read More »
For LBCA’s annual campaign to raise awareness of Lobular Breast Cancer during October, we’re setting out to Talk About Lobular Breast Cancer across the country, September
The Lobular Breast Cancer Awareness Tour Launches Saturday, Sept. 26th! Read More »
It’s Time to Talk About Lobular Breast Cancer! For LBCA’s annual campaign to raise awareness of Lobular Breast Cancer during October, Breast Cancer Awareness Month,
LBCA Lobular Breast Cancer Cross-Country Awareness Tour Sept. 26th – Oct. 15th, 2026 Read More »
A major milestone for the lobular breast cancer research community was attained with the launch of the Lobular American Research Consortium (LARC), the first national,
Lobular Breast Cancer Alliance (LBCA) is proud to celebrate two members of our team who were recently named to OncoDaily’s 100 Most Influential Cancer Survivors
LBCA Staff Recognized in Oncodaily’s 100 Influential Cancer Survivors on Social Media Read More »
Dr. Gary Ulaner elected President of the Society of Nuclear Medicine and Molecular Imaging Congratulations to LBCA Scientific Advisory Board member, Dr. Gary Ulaner on
New Local Advocacy Team Launches in Michigan! LBCA’s fourth Local Advocacy Team (LAT) has launched in Michigan and will be run by LBCA LAT Ambassadors
New Local Advocacy Team Launches in Michigan! Read More »
Thanks to the $1 Million gift made by Dr. Shannon Klingman, physician, lobular breast cancer survivor, and founder of Lume Deodorant, LBCA has launched a
Members of the Lobular Breast Cancer Alliance community, I am Bob McDevitt, Chair of the LBCA Board of Directors, writing on behalf of the Board
Exciting Opportunity to Explore a Role on the LBCA Board of Directors Read More »
Participation in clinical trials is one way that patients who are affected by ILC can help advance the understanding of lobular breast disease. These are
New ILC Clinical Trials Now Open Read More »
LBCA is proud to announce we’ve issued another ILC research grant solicitation. The LBCA Early Investigator Invasive Lobular Carcinoma Research Grant solicitation was just issued
The Lobular Breast Cancer Alliance and Susan G. Komen are excited to announce the grant recipients of the Susan G. Komen-Lobular Breast Cancer Alliance Metastatic
LBCA Patient Advocates Jade Moran and Janice Axelrod recently interviewed LBCA’s 2 newest Scientific Advisory Board Members Jade Moran interviewed new SAB Member Dr. Pooja Advani,
METAvivor, in partnership with LBCA is launching a new virtual peer-to-peer support group specifically for individuals living with Stage IV metastatic invasive lobular carcinoma (mILC).
New Metastatic ILC Support Group through Metavivor and LBCA Read More »
Lobular breast cancer and LBCA advocacy was more visible than ever before at this year’s San Antonio Breast Cancer Symposium (Dec. 9–12, 2025), the largest,
LBCA and ILC Research at SABCS 2025: Advancing Lobular Research Together Read More »
"*" indicates required fields
